Baoding Zhang
Impact in
- Aging top 5%
- Genetics, Aging, and Longevity in Model Organisms
-
- Metabolism, Diabetes, and Cancer
- Gut microbiota and health
Papers in
-
- Nanoparticle-Based Drug Delivery 3
-
- Metabolism, Diabetes, and Cancer 2
- Protein Degradation and Inhibitors 2
- Cancer-related gene regulation 2
- RNA Interference and Gene Delivery 1
- Co-authors
- Xianming Deng (11 shared papers)Haifeng Yuan (1 shared paper)Jianbo Zhao (1 shared paper)Liming Zhou (1 shared paper)Yanghai Gui (1 shared paper)Yingfan Liu (1 shared paper)Shaoming Fang (1 shared paper)Li Li (3 shared papers)
- Journals
- European Journal of Medicinal Chemistry (3 papers)Nature (2 papers)Advanced Functional Materials (2 papers)Nanoscale (1 paper)Signal Transduction and Targeted Therapy (1 paper)
- Partner nations
- ChinaFinlandNetherlands
In The Last Decade
Baoding Zhang
16 papers receiving 746 citations
Baoding Zhang's Hit Papers
Peers
Comparison fields: 5 of 83
- Aging 47
- Molecular Biology 308
- Geriatrics and Gerontology 11
- Epidemiology 75
- Biomaterials 29
Countries citing papers authored by Baoding Zhang
This map shows the geographic impact of Baoding Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baoding Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baoding Zhang more than expected).
Fields of papers citing papers by Baoding Zhang
This network shows the impact of papers produced by Baoding Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baoding Zhang. The network helps show where Baoding Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Baoding Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Low-dose metformin targets the lysosomal AMPK pathway through PEN2 Hit paper breakdown → | 2022 | 480 |
| 2 | 2024 | 63 | |
| 3 | 2022 | 61 | |
| 4 | 2019 | 43 | |
| 5 | 2023 | 24 | |
| 6 | 2022 | 19 | |
| 7 | 2020 | 14 | |
| 8 | 2020 | 13 | |
| 9 | 2022 | 13 | |
| 10 | 2023 | 9 | |
| 11 | 2025 | 5 | |
| 12 | 2022 | 3 | |
| 13 | 2025 | 3 | |
| 14 | 2025 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2026 | 1 | |
| 17 | 2025 | 0 |
About Baoding Zhang
Baoding Zhang is a scholar working on Biomaterials, Molecular Biology, Pulmonary and Respiratory Medicine, Aging and Organic Chemistry, having authored 17 papers that have together received 753 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Lung Cancer Treatments and Mutations (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Protein Degradation and Inhibitors (2 papers), Cancer-related gene regulation (2 papers), Cardiac Ischemia and Reperfusion (1 paper), RNA Interference and Gene Delivery (1 paper) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Aging (47 citations), Molecular Biology (308 citations), Geriatrics and Gerontology (11 citations), Epidemiology (75 citations) and Biomaterials (29 citations). Baoding Zhang has collaborated with scholars based in China, Finland and Netherlands. Frequent co-authors include Xianming Deng, Haifeng Yuan, Jianbo Zhao, Liming Zhou, Yanghai Gui, Yingfan Liu, Shaoming Fang, Li Li, Yaohui He and Han Jie Gao. Their work appears in journals such as European Journal of Medicinal Chemistry, Nature, Advanced Functional Materials, Nanoscale and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.